Royalty Pharma (RPRX) Shares Outstanding (Entity) (2020 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.61 Bn | 58.43 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.71 Bn | 51.57 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.24 Bn | 31.93 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.60 Bn | 27.76 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Incyte | 25.52 Bn | 20.99 Bn | 1.57 Bn | 200.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 575.00 Mn |
| Mar 31, 2026 | 576.19 Mn |
| Dec 31, 2025 | 577.11 Mn |
| Sep 30, 2025 | 579.02 Mn |
| Jun 30, 2025 | 583.17 Mn |
| Mar 31, 2025 | 566.46 Mn |
| Dec 31, 2024 | 589.11 Mn |
| Sep 30, 2024 | 589.18 Mn |
| Jun 30, 2024 | 594.39 Mn |
| Mar 31, 2024 | 597.44 Mn |
| Dec 31, 2023 | 597.44 Mn |
| Sep 30, 2023 | 598.39 Mn |
| Jun 30, 2023 | 601.82 Mn |
| Mar 31, 2023 | 607.23 Mn |
| Dec 31, 2022 | 607.22 Mn |
| Sep 30, 2022 | 607.22 Mn |
| Jun 30, 2022 | 607.22 Mn |
| Mar 31, 2022 | 607.18 Mn |
| Dec 31, 2021 | 607.18 Mn |
| Sep 30, 2021 | 607.17 Mn |